Bristol Myers Squibb (BMYMP) Consolidated Net Income (2016 - 2025)
Bristol Myers Squibb (BMYMP) has disclosed Consolidated Net Income for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.
- Quarterly Consolidated Net Income rose 1328.95% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.1 billion through Dec 2025, up 178.99% year-over-year, with the annual reading at $7.1 billion for FY2025, 178.99% up from the prior year.
- Consolidated Net Income for Q4 2025 was $1.1 billion at Bristol Myers Squibb, down from $2.2 billion in the prior quarter.
- The five-year high for Consolidated Net Income was $2.5 billion in Q1 2025, with the low at -$11.9 billion in Q1 2024.
- Average Consolidated Net Income over 5 years is $976.1 million, with a median of $1.6 billion recorded in 2022.
- The sharpest move saw Consolidated Net Income soared 1426.25% in 2021, then tumbled 625.28% in 2024.
- Over 5 years, Consolidated Net Income stood at $2.4 billion in 2021, then fell by 14.63% to $2.0 billion in 2022, then fell by 12.99% to $1.8 billion in 2023, then tumbled by 95.69% to $76.0 million in 2024, then surged by 1328.95% to $1.1 billion in 2025.
- According to Business Quant data, Consolidated Net Income over the past three periods came in at $1.1 billion, $2.2 billion, and $1.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.